A possible silver lining for Australia's biotech innovators after bombshell Myriad decision
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
@IAM_magazine InterDigital not messing around citing yesterday's Qualcomm decision in new filing as they move to have Lenovo anti… https://t.co/LZmtw1OM93 Read more
@IAM_magazine The smart money was on a Qualcomm victory in FTC appeal but not many expected such a sweeping win - the market reac… https://t.co/eAZsB9wG28 Read more
@IAM_magazine Compulsory licensing of covid-19 treatments unlikely in China, Japan and South Korea, but it may be a different sto… https://t.co/BqKIILYigG Read more
@IAM_magazine India's government makes a slate of appellate appointments in bid to address backlog of IP cases… https://t.co/RacoUiLltU Read more